Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06807502
NA

Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device

Sponsor: ScreenCell

View on ClinicalTrials.gov

Summary

Liquid biopsy is a noninvasive method for detecting and quantifying circulating tumor cells (CTCs). Thanks to ScreenCell technology, this study aims to evaluate the evolution of the number of CTCs during breast cancer follow-up. The identification and characterization of CTCs would make it possible to obtain information on the stage and molecular characteristics of cancer during follow-up

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

93

Start Date

2025-02-24

Completion Date

2026-11-30

Last Updated

2025-03-11

Healthy Volunteers

Yes

Interventions

DEVICE

The DM/DIV ScreenCell is the experimental product studied during this research

The product is not used directly on the subject, but on a blood sample taken from the participant.

Locations (1)

CMC Ambroise Paré Hartmann

Neuilly-sur-Seine, France